En Es
Categories

Industry News


Software para la TC de tórax basada en IA de Siemens Healthineers recibe aprobación de la FDA de los EUA

By Medimaging en español staff writers
23 Oct 2019

Imagen: AI-Rad Companion Chest CT genera automáticamente informes estandarizados, reproducibles y cuantitativos en formato DICOM SC (Fotografía cortesía de Siemens Healthineers).La Administración de Medicamentos y Alimentos de los Estados Unidos (FDA) aprobó tres módulos de AI-Rad Companion Chest CT, un asistente de software inteligente de Siemens Healthineers (Erlangen, Alemania) que lleva la inteligencia artificial (IA) a la tomografía computarizada (TC). Representando al primer asistente inteligente de la nueva plataforma AI-Rad Companion, AI-Rad Companion Chest CT, ayuda a los radiólogos a interpretar imágenes del tórax (pecho) rápidamente con la exactitud y precisión deseadas, y documenta automáticamente estos hallazgos como informes estructurados.

Los algoritmos en AI-Rad Companion Chest CT fueron entrenados en extensos conjuntos de datos y revisados por especialistas clínicos calificados para proporcionar segmentación, medición y resaltado de estructuras anatómicas clave, para apoyar el análisis cuantitativo y cualitativo. Usando imágenes de TC del tórax, el AI-Rad Companion Chest CT diferencia entre varias estructuras en esa región, incluidos los pulmones, el corazón y la aorta, las resalta individualmente y marca y mide anormalidades potenciales, como las calcificaciones coronarias.

Es compatible con una variedad de tareas, incluida la detección automática de lesiones, localización de anomalías y medición de lesiones pulmonares; cuantificación de parénquima de baja atenuación por lóbulo; visualización mejorada de lesiones pulmonares; segmentación automática de lóbulos pulmonares y visualización mejorada del parénquima de baja atenuación; segmentación y medición de diámetros máximos de la aorta torácica; cuantificación del volumen total de calcio en las arterias coronarias; y la detección de nueve puntos de referencia anatómicos identificados por las pautas de la Asociación Americana de Cardiología (AHA).

Con base en el análisis respaldado por IA, AI-Rad Companion Chest CT genera automáticamente informes estandarizados, reproducibles y cuantitativos en formato SC de imágenes digitales y comunicaciones en medicina (DICOM). Además de reducir el tiempo dedicado a la documentación de resultados manuales, los radiólogos pueden acceder a estos informes en el sistema de archivo y comunicación de imágenes (PACS) en la rutina clínica. El AI-Rad Companion Chest CT también resalta los cambios clínicamente relevantes potenciales que, de otro modo, podrían pasar desapercibidos porque no eran la indicación principal para el examen.

“AI-Rad Companion Chest CT se basa en nuestra experiencia de décadas en inteligencia artificial y aprendizaje automático, digitalizando la atención médica y ayudando a los proveedores a realizar la interpretación de imágenes de múltiples órganos del tórax con detección, exactitud y precisión mejoradas, lo que potencialmente puede mejorar los resultados”, dijo David Pacitti, presidente y jefe de las Américas en Siemens Healthineers.

Enlace relacionado:
Siemens Healthineers



E-mail Print
FaceBook Twitter Google+ Linked in

Siemens Healthineers

Provides customized electronic systems and advanced imaging, diagnostics, therapy, and healthcare IT solutions for the medical industry
Silver member
More info

More articles about Siemens Healthineers

15 Oct 2019
Siemens Healthineers’ AI-Based Chest CT Software Receives US FDA Clearance
The US Food and Drug Administration (FDA) has cleared three modules of AI-Rad Companion Chest CT, an intelligent software assistant from Siemens Healthineers that brings artificial intelligence (AI) to computed tomography (CT).
Read More
13 Aug 2019
Siemens Healthineers' Acquires Corindus to Enhance Robotic-Assisted Interventions
Siemens Healthineers AG has entered into a merger agreement with Corindus Vascular Robotics, Inc. to acquire the company, which offers a robotic treatment platform for the major vascular therapeutic markets, including coronary, peripheral vascular and neurovascular interventions.
Read More
05 Aug 2019
Siemens Healthineers Receives Recognition AI Applications in Radiology
Based on its recent analysis of the global precision imaging market, Frost & Sullivan, a growth strategy consulting and research firm, has recognized Siemens Healthineers with the 2019 Global Visionary Innovation Leadership Award for leading the effort to establish imaging as an active contributor to precision medicine.
Read More
07 Feb 2019
Global MRI Systems Market to Grow by USD 1.5 Billion in 2019-2023
The global MRI systems market size is projected to grow at a CAGR of more than 5%, or by almost USD 1.58 billion, during the forecast period 2019-2023, driven primarily by technological advances.
Read More
12 Nov 2018
Siemens Healthineers and Primary Health Care Enter Contract for In Vitro Diagnostics
Siemens Healthineers has entered into a strategic partnership with Australian integrated healthcare provider Primary Health Care to deploy more than 70 Atellica Solution immunoassay and clinical chemistry analyzers, marking the largest contract ever for in vitro diagnostics testing in the country.
Read More
06 Jun 2018
Siemens Healthineers and ScreenPoint Medical to Develop AI-Based Apps
Siemens Healthineers and ScreenPoint Medical have entered into a partnership to develop artificial intelligence (AI)-based applications for breast imaging. As part of the arrangement, Siemens Healthineers will also acquire a strategic minority stake in ScreenPoint Medical.
Read More
26 Apr 2018
Siemens Healthineers Launches Thermocycler with AI-Powered Software
Siemens Healthineers launched a new molecular thermocycler, the Fast Track cycler (FTC), and the complementary new FastFinder software at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2018). The compact FTC allows laboratories of all sizes to implement molecular testing with simplicity and speed, while the FastFinder software improves workflow using Artificial Intelligence (AI)-powered automation.
Read More
27 Feb 2018
Siemens Healthineers AG IPO Planned for First Half of 2018
Global technology powerhouse Siemens AG and its separately managed healthcare business, Siemens Healthineers have announce that the planned IPO of Siemens Healthineers AG is expected to be completed in the first half of calendar year 2018, subject to capital market conditions.
Read More

Additional news

27 Jan 2020
JNJ Acquires Remaining Stake in Verb Surgical
 Johnson & Johnson (New Brunswick, N.J., USA) has acquired the remaining stake in Verb Surgical Inc. (Santa Clara, CA, USA), following a successful strategic collaboration with Verily, an Alphabet company. Verb Surgical's robotics and data science capabilities, combined with Johnson & Johnson's health care leadership and global reach, aim to make medical interventions smarter, less invasive and more personalized.
Read More
22 Jan 2020
Global Point of Care Testing (POCT) Market to Reach USD 46.7 Billion by 2024
 The global point of care testing (POCT) market is expected to surpass USD 37 billion by 2025, driven mainly by the migration of POCT from the hospital environment to a range of medical environments, including the workplace, home, disaster care and most recently, convenience clinics. POCT now appears to be headed for a bigger role in diagnosis and monitoring patient care. Additionally, growing awareness about early disease diagnosis and prevention has stimulated the demand for POCT for detecting cancer and infectious disease in the early stages. Moreover, the rising incidence of infectious diseases and chronic conditions, such as cardiovascular diseases and diabetes in the developing countries such as India and China, is stimulating the demand for POCT services.
Read More
16 Jan 2020
Radiomic Algorithm Predicts if Patient’s Cancer Can Return 10 Years After Treatment
 A new study by researchers at Penn Medicine (Philadelphia, PA, USA) has found that Magnetic Resonance Imaging (MRI) and an emerging field of medicine called radiomics — which uses algorithms to extract a large amount of features from medical images — could help to characterize the heterogeneity of cancer cells within a tumor and allow for a better understanding of the causes and progression of a person’s individual disease.
Read More
13 Jan 2020
PENTAX Medical Clears CE Mark for New AI-Assisted Polyp Detector
 PENTAX Medical (Tokyo, Japan) has cleared CE mark for DISCOVERY, its Artificial Intelligence (AI) assisted polyp detector designed to support endoscopists in finding potential polyps during a colorectal examination.
Read More
07 Jan 2020
New AI Model Identifies Women Facing Future Risk of Breast Cancer
 Researchers from the Karolinska Institute (Stockholm, Sweden) have developed a sophisticated type of artificial intelligence (AI) which can outperform existing models at predicting which women are at future risk of breast cancer.
Read More
07 Jan 2020
Global EEG Devices Market to Reach USD 2.20 Billion in 2027
 The global EEG (Electroencephalography) devices market was valued at USD 1.12 billion in 2018 and is projected to grow at a CAGR of 7.8 % over the forecast period 2019-2027 to reach USD 2.20 billion in 2027, driven mainly by the increasing prevalence of sleep disorders.

Read More
06 Jan 2020
Google AI System Beats Doctors in Detecting Breast Cancer
 A team of researchers from Google Health (Palo Alto, CA, USA) have developed an artificial intelligence (AI) model which can spot breast cancer in de-identified screening mammograms (where identifiable information has been removed) with greater accuracy, fewer false positives, and fewer false negatives than experts. This can find future applications wherein the model could support radiologists performing breast cancer screenings.
Read More
03 Jan 2020
Nova Biomedical Launches New BioProfile FLEX2 On-Line Autosampler
 Nova Biomedical (Waltham, MA, USA) has launched the BioProfile FLEX2 On-Line Autosampler (OLS), a modular system that connects as many as 10 bioreactors to one FLEX2 analyzer for up to three weeks of walkaway, automated sampling, analysis, and feedback control of key cell culture analytes. The FLEX2 measures up to 16 tests, including pH, gases, metabolites, osmolality, cell density, and cell viability.
Read More
03 Jan 2020
Global Hematology Diagnostic Devices and Equipment Market to Reach USD 2.35 Billion by 2022
 The global hematology diagnostic devices and equipment market was valued at about USD 1.9 billion in 2018 and is projected to grow to at a CAGR of 5.5% to USD 2.35 billion in 2022. The market growth is driven mainly by an increase in the use of hematology diagnostic devices due to the rising prevalence of blood disorders which affect millions of people each year across the world, irrespective of age, race, and sex.
Read More
Copyright © 2000-2020 TradeMed.com. All rights reserved. | Terms And Conditions